Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by james700on May 27, 2021 12:58pm
67 Views
Post# 33276278

RE:Pump and dump

RE:Pump and dump
Look no further than July 1st and July 4th of 2020, for the artificial rise in stock price, actually exceeded $30+. Lucky a friend told me and I was able to sell my $15 shares for about $22 and got most of the extra money I threw in to be part of the new company LMNL. Unfortunately, the plan is not to build anything but rather dismantle and hope that retail buy up the remaining $150M worth of PAPER they are offering... WHO BELIEVES THAT THE SMALL MOLECULE BUSINESS WILL GENERATE PROFIT ANYTIME IN THE NEXT 2-5 YEARS????
<< Previous
Bullboard Posts
Next >>